Carlomagno A - Search Results

1

Impaired inactive to active kallikrein conversion in human salt-sensitive hypertension.

Bellini C, Ferri C, Carlomagno A, Necozione S, Lepore AR, Desideri G, Santucci A. Bellini C, et al. Among authors: carlomagno a. J Am Soc Nephrol. 1996 Dec;7(12):2565-77. doi: 10.1681/ASN.V7122565. J Am Soc Nephrol. 1996. PMID: 8989735 Clinical Trial.

2

Urinary kallikrein and salt sensitivity in essential hypertensive males.

Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A. Ferri C, et al. Among authors: carlomagno a. Kidney Int. 1994 Sep;46(3):780-8. doi: 10.1038/ki.1994.333. Kidney Int. 1994. PMID: 7996800 Free article. Clinical Trial.

3

The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.

Bellini C, Ferri C, Piccoli A, Carlomagno A, Di Francesco L, Bonavita MS, Santucci A, Balsano F. Bellini C, et al. Among authors: carlomagno a. Nephron. 1993;65(1):28-35. doi: 10.1159/000187436. Nephron. 1993. PMID: 8413787 Clinical Trial.

4

Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension.

Ferri C, Bellini C, Piccoli A, Carlomagno A, Bonavita MS, Santucci A, Balsano F. Ferri C, et al. Among authors: carlomagno a. Hypertension. 1993 Jun;21(6 Pt 1):875-81. doi: 10.1161/01.hyp.21.6.875. Hypertension. 1993. PMID: 8500867 Clinical Trial.

5

Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients.

Ferri C, Bellini C, Carlomagno A, Desideri G, Santucci A. Ferri C, et al. Among authors: carlomagno a. J Am Soc Nephrol. 1996 Mar;7(3):443-53. doi: 10.1681/ASN.V73443. J Am Soc Nephrol. 1996. PMID: 8704111 Clinical Trial.

6

[The efficacy and tolerance of orally administered kallikrein in patients with essential arterial hypertension].

Bellini C, Carlomagno A, Piccoli A, Di Francesco L, Torregrossa G, Leonetti Luparini R, Germanò G, Giarrizzo C, Ferri C, Santucci A, et al. Bellini C, et al. Among authors: carlomagno a. Ann Ital Med Int. 1991 Oct-Dec;6(4):369-74. Ann Ital Med Int. 1991. PMID: 1804283 Clinical Trial. Italian.

7

[Oral administration of extracted kallikrein to patients with essential arterial hypertension].

Bellini C, Carlomagno A, Piccoli A, Di Francesco L, Ferri C, Luparini RL, Germanò G, Giarrizzo C, Santucci A, Balsano F. Bellini C, et al. Among authors: carlomagno a. Clin Ter. 1991 Oct 15-31;139(1-2):3-8. Clin Ter. 1991. PMID: 1837764 Italian.

8

Urinary kallikrein excretion and plasma atrial natriuretic peptide in human salt-sensitive hypertension.

Ferri C, Bellini C, Carlomagno A, Baldoncini R, De Siati L, Perrone A, Santucci A, Balsano F. Ferri C, et al. Among authors: carlomagno a. J Hypertens Suppl. 1993 Dec;11(5):S212-3. J Hypertens Suppl. 1993. PMID: 8158350 Clinical Trial. No abstract available.

9

Increased sodium, potassium cotransport activity in salt-sensitive essential hypertensive patients.

Cacciafesta M, Ferri C, Carlomagno A, Piccirillo G, De Angelis C, Santucci A, Guidoni L, Luciani AM, Rosi A, Viti V, et al. Cacciafesta M, et al. Among authors: carlomagno a. J Hypertens Suppl. 1993 Dec;11(5):S254-5. J Hypertens Suppl. 1993. PMID: 8158371 No abstract available.

10

Erythrocyte Na-K-Cl cotransport activity in low renin essential hypertensive patients. A 23Na nuclear magnetic resonance study.

Cacciafesta M, Ferri C, Carlomagno A, De Angelis C, Scuteri A, Guidoni L, Luciani AM, Rosi A, Viti V, Santucci A, et al. Cacciafesta M, et al. Among authors: carlomagno a. Am J Hypertens. 1994 Feb;7(2):151-8. doi: 10.1093/ajh/7.2.151. Am J Hypertens. 1994. PMID: 8179850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters